Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

C Mayerat1, A Mantegani, P C Frei

  • 1Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.

Journal of Viral Hepatitis
|December 22, 1999
PubMed

Insights

Hepatitis B virus (HBV) genotype A is strongly linked to chronic infections, while genotype D is associated with acute, resolving hepatitis. This finding suggests HBV genotypes influence infection outcomes and disease progression.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis B virus (HBV) infection can lead to chronic liver disease in 5-10% of adults.
  • HBV genotypes A and D are prevalent in Western Europe, accounting for 90% of infections.
  • The relationship between HBV genotype and clinical outcome requires further investigation.

Purpose of the Study:

  • To investigate the association between HBV genotypes A and D and the clinical outcome of hepatitis B infection.
  • To compare the prevalence of HBV genotypes A and D in patients with chronic active hepatitis versus acute resolving hepatitis.

Main Methods:

  • Genotyping of HBV in patients with chronic active hepatitis and acute resolving hepatitis.
  • Statistical analysis (Fisher's exact test) to determine the association between genotype and clinical outcome.

Main Results:

  • HBV genotype A was prevalent in 28/35 patients with chronic active hepatitis.
  • HBV genotype D was prevalent in 24/30 patients with acute resolving hepatitis.
  • A statistically significant association was found between HBV genotype A and chronic infection (P < 0.0001).

Conclusions:

  • HBV genotype A is significantly associated with chronic hepatitis B infection.
  • HBV genotype D is significantly associated with acute, resolving hepatitis B infection.
  • HBV genotypes may play a crucial role in the virus-host relationship and disease progression.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...